Dolasetron

Table   Graphic     exposition period:

Neuro-developmental disorders
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROB
Neuro-developmental disorders (as a whole)1.60 [0.42, 6.07]-1 study1389not evaluable unclear

Hide endpoints reported in only one study ...